ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 191 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $689,000 | +37.0% | 13,424 | +59.7% | 0.01% | +66.7% |
| Q4 2019 | $503,000 | +82.2% | 8,407 | +11.6% | 0.00% | +50.0% |
| Q3 2019 | $276,000 | -72.5% | 7,531 | -65.1% | 0.00% | -75.0% |
| Q2 2019 | $1,003,000 | +100.6% | 21,563 | +72.9% | 0.01% | +166.7% |
| Q1 2019 | $500,000 | -75.3% | 12,468 | -71.7% | 0.00% | -62.5% |
| Q4 2018 | $2,028,000 | +500.0% | 44,094 | +479.6% | 0.01% | +300.0% |
| Q3 2018 | $338,000 | +7.3% | 7,608 | -5.4% | 0.00% | 0.0% |
| Q2 2018 | $315,000 | -50.9% | 8,044 | -9.4% | 0.00% | -50.0% |
| Q1 2018 | $642,000 | -3.2% | 8,879 | -11.9% | 0.00% | -20.0% |
| Q4 2017 | $663,000 | – | 10,077 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
| Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
| Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
| Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
| Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
| XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |